{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "12510944",
  "DateCompleted": {
    "Year": "2003",
    "Month": "02",
    "Day": "03"
  },
  "DateRevised": {
    "Year": "2013",
    "Month": "11",
    "Day": "21"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "1368-5031",
      "JournalIssue": {
        "Volume": "56",
        "Issue": "10",
        "PubDate": {
          "Year": "2002",
          "Month": "Dec"
        }
      },
      "Title": "International journal of clinical practice",
      "ISOAbbreviation": "Int J Clin Pract"
    },
    "ArticleTitle": "Tolerability of ibuprofen, aspirin and paracetamol for the treatment of cold and flu symptoms and sore throat pain.",
    "Pagination": {
      "StartPage": "732",
      "EndPage": "734",
      "MedlinePgn": "732-4"
    },
    "Abstract": {
      "AbstractText": [
        "This double-blind randomised study compared the tolerability of ibuprofen (up to 1.2 g daily), aspirin and paracetamol (both up to 3 g daily) for up to seven days, in patients with mild to moderate pain resulting from cold/flu symptoms or sore throat (CF/ST) (n = 2,815). The main outcome was the rate of significant adverse events (SGAE). Rates of SGAE for ibuprofen, aspirin and paracetamol were respectively 12.0%, 15.7% and 12.3%. Ibuprofen was significantly better tolerated than aspirin (p = 0.02) and had comparable tolerability with paracetamol. The latter was also true for total digestive system events and for abdominal pain and dyspepsia. In conclusion, in patients with CF/ST, ibuprofen used at over-the-counter doses is as well tolerated as paracetamol and much better tolerated than aspirin."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pharmacology, University Victor Segalen, Bordeaux, France."
          }
        ],
        "LastName": "Moore",
        "ForeName": "N",
        "Initials": "N"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Le Parc",
        "ForeName": "J M",
        "Initials": "JM"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "van Ganse",
        "ForeName": "E",
        "Initials": "E"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Wall",
        "ForeName": "R",
        "Initials": "R"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Schneid",
        "ForeName": "H",
        "Initials": "H"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Cairns",
        "ForeName": "R",
        "Initials": "R"
      }
    ],
    "PublicationTypeList": [
      "Clinical Trial",
      "Journal Article",
      "Randomized Controlled Trial"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "India",
    "MedlineTA": "Int J Clin Pract",
    "NlmUniqueID": "9712381",
    "ISSNLinking": "1368-5031"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Analgesics, Non-Narcotic"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Anti-Inflammatory Agents, Non-Steroidal"
    },
    {
      "RegistryNumber": "362O9ITL9D",
      "NameOfSubstance": "Acetaminophen"
    },
    {
      "RegistryNumber": "R16CO5Y76E",
      "NameOfSubstance": "Aspirin"
    },
    {
      "RegistryNumber": "WK2XYI10QM",
      "NameOfSubstance": "Ibuprofen"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "adverse effects"
      ],
      "DescriptorName": "Acetaminophen"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [
        "adverse effects"
      ],
      "DescriptorName": "Analgesics, Non-Narcotic"
    },
    {
      "QualifierName": [
        "adverse effects"
      ],
      "DescriptorName": "Anti-Inflammatory Agents, Non-Steroidal"
    },
    {
      "QualifierName": [
        "adverse effects"
      ],
      "DescriptorName": "Aspirin"
    },
    {
      "QualifierName": [
        "complications",
        "drug therapy"
      ],
      "DescriptorName": "Common Cold"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Double-Blind Method"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "adverse effects"
      ],
      "DescriptorName": "Ibuprofen"
    },
    {
      "QualifierName": [
        "complications",
        "drug therapy"
      ],
      "DescriptorName": "Influenza, Human"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [
        "etiology",
        "prevention & control"
      ],
      "DescriptorName": "Pain"
    },
    {
      "QualifierName": [
        "complications",
        "drug therapy"
      ],
      "DescriptorName": "Pharyngitis"
    },
    {
      "QualifierName": [
        "complications",
        "drug therapy"
      ],
      "DescriptorName": "Respiratory Tract Infections"
    }
  ]
}